Net Cash Provided by (Used in) Operating Activities |
-485K |
USD |
+81.7% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
2.92M |
USD |
+388% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
34.9M |
shares |
+2.29% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-485K |
USD |
-278% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
200K |
USD |
-80% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
20.8M |
USD |
+29.1% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
20.8M |
USD |
+29.1% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.96M |
USD |
+346% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
+700% |
Q1 2023 |
Q1 2023 |
Additional Paid in Capital |
108M |
USD |
+3.61% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2023 |
Q1 2023 |
Share-based Payment Arrangement, Expense |
746K |
USD |
0% |
Q3 2024 |
Q3 2024 |
Interest Expense |
50K |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2023 |
Q1 2023 |